AK Steck, GJ Klingensmith, R Fiallo-Scharer - Pediatric Diabetes, 2007 - interscience.wiley.com Abstract: Since the findings of the Diabetes Control and Complications Trial
became public in 1993, intensive insulin therapy has been recommended for all
children. However, successful implementation remains a challenge because of ... Cited by 7 - Related articles - BL Direct - All 3 versions
- ►utsouthwestern.edu [PDF] CCW Hsia, P Raskin - Diabetes Technology & Therapeutics, 2007 - liebertonline.com Diabetic microangiopathy targets the lung as it does other organs. Even though
respiratory dysfunction in most patients with diabetes is subclinical and rarely
the presenting complaint, there are several reasons why pulmonary ... Cited by 7 - Related articles - BL Direct - All 9 versions
AL Comulada, E Renard, M Nakano, N Rais, X … - Diabetes Technology & Therapeutics, 2009 - liebertonline.com Abstract Background: Patients with type 1 diabetes may prefer features of AIRÒ
inhaled insulin (developed by Alkermes, Inc. [Cambridge, MA] and Eli Lilly and
Company [Indianapolis, IN]; AIR is a registered trademark of Alkermes, ... Cited by 5 - Related articles - All 3 versions
- ►nih.gov - Free from Publisher WW Chance, C Rhee, C Yilmaz, DM Dane, ML … - Diabetes care, 2008 - Am Diabetes Assoc RESULTS—In type 2 diabetic patients, peak levels of oxygen uptake, Q̇ and DL
CO , DL NO , and V C at exercise were 10–25% lower compared with those in
control subjects. In nonobese patients (BMI <30 kg/m 2 ), reductions in DL ... Cited by 4 - Related articles - All 7 versions
JS Skyler, PA Hollander, L Jovanovic, S … - Diabetes research and clinical practice, 2008 - Elsevier Small treatment group differences favoring SC insulin in change from baseline
forced expiratory volume in 1 s (FEV 1 ) and carbon monoxide diffusing capacity
(DL CO ) occurred early and were non-progressive. These differences ... Cited by 5 - Related articles - All 2 versions
- ►ersj.org.uk MC Liu, RJ Riese, K Van Gundy, P Norwood, … - European Respiratory Journal, 2008 - ersj.org.uk 1 Divisions of Allergy and Clinical Immunology, Pulmonary and Critical Care
Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, 2 Pfizer
Global Research and Development, New London, CT, 3 Division of Pulmonary ... Cited by 4 - Related articles - All 8 versions
S Del Prato, L Blonde, L Martinez, B Goke, V … - Diabetic Medicine, 2008 - interscience.wiley.com Methods During a randomized controlled trial in primary, secondary and tertiary
care in Europe and North America, 739 patients using ≥ 2 oral glucose-lowering
agents with glycated haemoglobin (HbA 1c ) ≥ 8.0% were assigned to two ... Cited by 2 - Related articles - BL Direct - All 4 versions
S Bellary, AH Barnett - Current Diabetes Reports, 2007 - Springer Inhaled insulin is a recent advance in insulin delivery that promises to be an
effective alternative to subcutaneous insulin. Several insulin delivery systems
are currently in development and the first of these has been approved for ... Cited by 2 - Related articles - BL Direct - All 2 versions
BL Silverman, CJ Barnes, BN Campaigne, … - Vascular Health and Risk Management, 2007 - pubmedcentral.nih.gov Diabetes mellitus is a significant worldwide health problem, with the incidence
of type 2 diabetes increasing at alarming rates. Insulin resistance and
dysregulated blood glucose control are established risk factors for ... Cited by 1 - Related articles - BL Direct - All 8 versions
